Obesity
Obesity means excess body fat that can affect health. It is not just due to overeating or lack of willpower; it can be influenced by genetics, hormones, insulin resistance, thyroid problems, PCOS, Cushing’s syndrome, medicines, stress, poor sleep, irregular eating habits, and lifestyle. Belly fat is especially important because it is strongly linked to diabetes, fatty liver, sleep apnea, high BP, cholesterol problems, heart disease, joint pains, infertility, pregnancy complications, and some cancers.
Before starting treatment, an endocrinologist may assess weight, BMI, waist size, sugar levels, cholesterol, liver and kidney function, thyroid status, and selected hormonal causes when needed. Even 5–10% weight loss can improve diabetes, BP, fatty liver, PCOS, sleep apnea, energy, and overall health.
Treatment includes a practical diet plan, calorie control, adequate protein, high-fibre foods, regular activity, and strength training to protect muscle. Weight-loss medicines such as GLP-1 medicines, semaglutide, tirzepatide, or other anti-obesity medicines may help selected patients. Gastric balloon, bariatric surgery, or metabolic surgery may be considered in suitable patients when lifestyle and medicines are not enough, but they are not shortcuts and need proper selection and follow-up.
An endocrinologist plays an important role in identifying hormonal and metabolic causes, choosing safe treatment options, monitoring side effects, preventing muscle loss and weight regain, and guiding sustainable, healthy weight loss.
Sleep Apnea
Sleep apnea is a condition where breathing repeatedly becomes shallow or briefly stops during sleep. Warning signs include loud snoring, choking or gasping during sleep, pauses in breathing, restless sleep, morning headache, daytime sleepiness, tiredness, poor concentration, mood changes, and poor work performance.
Sleep apnea is common in people with obesity, especially with belly fat or neck fat, but it can also occur in non-obese people. If untreated, it can worsen high BP, diabetes, insulin resistance, heart disease, stroke risk, weight gain, and overall quality of life.
An endocrinologist plays an important role because sleep apnea is closely linked with obesity, diabetes, thyroid problems, PCOS, insulin resistance, fatty liver, and metabolic syndrome. Proper weight management, sugar control, thyroid evaluation, lifestyle planning, and treatment of hormonal or metabolic problems can significantly improve sleep apnea and overall health.
Diagnosis is done with a sleep study, either at home or in a sleep lab. Treatment usually includes weight loss, regular exercise, avoiding alcohol and sleeping pills, improving sleep position, and CPAP therapy when needed. CPAP is safe and is the most reliable treatment for moderate to severe sleep apnea.
Surgery has a limited and selective role. It is not a guaranteed cure and works best only in carefully selected patients with a clear correctable airway blockage, such as large tonsils or specific structural problems. For most patients, long-term success depends more on weight reduction, metabolic health, CPAP when required, and regular follow-up.
Fatty Liver
Fatty liver means extra fat has collected in the liver. It is commonly linked to obesity, diabetes, insulin resistance, high cholesterol, PCOS, and metabolic syndrome, but it can also occur in lean people. Many patients have no symptoms, and liver blood tests may even be normal. In some people, fatty liver can progress to liver inflammation, fibrosis, cirrhosis, and may increase heart disease risk.
Evaluation may include liver blood tests, ultrasound, FIB-4 score, and FibroScan or liver elastography to assess liver fat and stiffness. Liver biopsy is needed only in selected cases.
Fatty liver can often improve with weight loss, healthy diet, regular exercise, good sugar and cholesterol control, and avoiding alcohol. Reducing sweets, fruit juices, soft drinks, refined carbohydrates, and excess calories is important. Medicines such as saroglitazar, GLP-1 medicines, tirzepatide, SGLT2 inhibitors, or newer drugs like resmetirom may help selected patients, especially those with diabetes, obesity, high triglycerides, MASH/NASH, or significant fibrosis, but they should be used only after proper medical evaluation.
An endocrinologist plays an important role because fatty liver is often part of a larger metabolic problem. With lifestyle treatment, metabolic control, regular monitoring, and specialist follow-up, fatty liver can often be controlled and even reversed in many patients.
GLP-1 Agonists
GLP-1 agonists are modern medicines used for type 2 diabetes, obesity, and weight management in suitable patients. Medicines such as semaglutide, liraglutide, and dulaglutide belong to this group, while tirzepatide is a related medicine that works on both GIP and GLP-1 pathways. These medicines help the body release insulin when sugar is high, reduce excess glucagon, slow stomach emptying, reduce appetite, decrease food cravings, and support weight loss. They may also help improve insulin resistance, fatty liver, PCOS-related weight issues, and heart-metabolic health in selected patients. GLP-1 medicines are available as daily or weekly injections, and oral semaglutide is available as a tablet. The injections are usually given under the skin and are generally not very painful. Common side effects include nausea, vomiting, acidity, constipation, loose motions, bloating, and reduced appetite; these can often be reduced by starting with a low dose, increasing slowly, eating smaller meals, avoiding oily foods, and drinking enough water. GLP-1 medicines usually do not cause low sugar by themselves, but low sugar risk may increase when used with insulin or sulfonylureas, so dose adjustment may be needed. They are not suitable for everyone and should be avoided during pregnancy, breastfeeding, and in certain medical conditions such as previous pancreatitis or specific thyroid cancer syndromes. Some patients may regain weight after stopping, so long-term lifestyle changes, adequate protein intake, resistance exercise, and follow-up are important to maintain results and reduce muscle loss.
Childhood Obesity
Childhood obesity means a child has excess body fat that can affect health. It is assessed using growth charts and BMI percentile, not adult BMI values. Childhood obesity is not always due to overeating alone; genetics, family habits, sleep problems, stress, screen time, reduced physical activity, medicines, and rarely hormone problems such as hypothyroidism or Cushing’s syndrome may contribute.
Obesity in children can increase the risk of insulin resistance, prediabetes, type 2 diabetes, fatty liver, high BP, high cholesterol, sleep apnea, joint pains, early puberty in girls, PCOS risk in adolescent girls, low confidence, mood issues, and difficulty with physical activity. Evaluation may include checking height, weight, BMI percentile, BP, sugar or HbA1c, cholesterol, liver and kidney function, thyroid test, vitamin D, and selected hormonal or genetic tests when needed.
Treatment should focus on health, not body shaming. Strict dieting and crash diets are not advised. Children need balanced meals with adequate protein, vegetables, fruits, fibre, regular physical activity, reduced sugary drinks, fruit juices, fried foods, bakery foods, ultra-processed foods, and limited screen time. Good sleep and family-based lifestyle changes are very important. In selected adolescents, medicines such as GLP-1 medicines or bariatric surgery may be considered only under specialist care. With early support, regular monitoring, and a positive family approach, childhood obesity can be managed safely and long-term health can improve.
Obesity Syndromes
Obesity syndromes are uncommon genetic or medical conditions where severe weight gain starts early in life and is often associated with other health or developmental problems. They are different from common obesity because the child may have excessive hunger, constant food-seeking behaviour, delayed milestones, learning difficulty, behavioural concerns, short height or poor growth, delayed puberty, vision or hearing problems, kidney or heart problems, or abnormal genital development. Important examples include Prader-Willi syndrome, Bardet-Biedl syndrome, Alström syndrome, and monogenic obesity due to genes affecting appetite control, such as leptin, leptin receptor, MC4R, POMC, or PCSK1.
Evaluation includes growth chart review, BMI percentile, hunger pattern, developmental history, family history, physical examination, and tests for sugar, cholesterol, liver function, thyroid, cortisol, vitamin D, and puberty hormones when needed. Genetic testing may be advised if obesity starts very early, is severe, or is associated with developmental delay, excessive hunger, vision problems, extra fingers or toes, kidney problems, or strong family history. Treatment focuses on structured meals, family supervision, healthy routines, physical activity, good sleep, behavioural support, and prevention of diabetes, fatty liver, sleep apnea, high BP, and cholesterol problems. Strict dieting or blaming the child should be avoided. Some patients may benefit from medicines, GLP-1 medicines in selected adolescents or adults, targeted therapy for certain genetic obesity disorders, or bariatric surgery in carefully selected cases. Long-term multidisciplinary care helps improve health, growth, confidence, and quality of life.